Phase 2 Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are at least 18 years old
- People who have signed and dated a consent form agreeing to take part
- People who are willing and available to follow all study procedures for the full duration of the trial
- People who have been diagnosed with prostate adenocarcinoma (a specific type of prostate cancer), confirmed through tissue testing, with a plan to treat it using radiation therapy aimed at curing the cancer
- People whose cancer can be seen on a prostate MRI scan and/or a specialised nuclear imaging scan (PSMA PET-CT), with biopsy results that match what the scans show
- People who are capable of causing a pregnancy and who agree to use condoms or other effective contraception with their partner during radiation treatment and for at least 6 months afterward
Who may not be able to join:
- People who have implants in both hips
- People who have previously had their prostate surgically removed
- People who have previously received any treatment for prostate cancer, such as focal therapy (note: people who started hormone therapy within the 90 days before joining the trial may still be considered eligible, as long as compatible scans were done within 4 months before starting that hormone therapy — confirm with trial site)
- People who have previously had radiation therapy to any area of the body that would need to be treated in this trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Tyler Seibert, MD, PhD, University of California, San Diego
Phone: (858) 822-5354
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Acute toxicity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.